Afinitor (Everolimus) Approved For Renal Angiomyolipomas By FDA
Medical News Today
Afinitor (everolimus) has been approved by the FDA for renal angiomyolipomas (non-cancerous kidney tumors) that do not require urgent surgery in patients with TSC (tuberous sclerosis complex). Tuberous sclerosis complex is a very rare genetic condition ...
US FDA approves Novartis' Afinitor to treat adult patients with kidney
FDA Expands Everolimus LabelMedPage Today
Novartis' Afinitor Gets FDA Okay for Treating Renal Angiomyolipoma Associated ...Genetic Engineering News
Pharmaceutical Business Review -Kansas City infoZine
all 9 news articles »